Pharmafile Logo

White Papers and Resources

Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.

What does the new NHS plan mean for pharma?

January 25, 2019 |  White Papers and Resources  |

Steve How and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of the NHS Long-term Plan

Read More

Brought to you by  Wilmington Healthcare 

NHS medicines optimisation milestone

December 10, 2018 |  White Papers and Resources  |

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry

Read More

Brought to you by  Wilmington Healthcare 

New local NHS models help to deliver integrated care

October 31, 2018 |  White Papers and Resources  |

Steve How, of Wilmington Healthcare, explains how health and social care groups are uniting within ‘neighbourhoods’

Read More

Brought to you by  Wilmington Healthcare 

How can pharma engage with key stakeholders on NHS service transformation?

August 17, 2018 |  White Papers and Resources  |

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change

Read More

Brought to you by  Wilmington Healthcare 

How can pharma support NHS service change?

June 5, 2018 |  White Papers and Resources  |

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, find some answers in NHS England guidance for commissioners

Read More

Brought to you by  Wilmington Healthcare 

How will new data protection law affect pharma?

May 2, 2018 |  White Papers and Resources  |

Sarah Eglington, of Wilmington Healthcare, explores how GDPR will change pharma’s relationship with healthcare professionals

Read More

Brought to you by  Wilmington Healthcare 

Unique forum will unite NHS and industry to drive innovation

April 18, 2018 |  White Papers and Resources  |

HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare

Read More

Brought to you by  Wilmington Healthcare 

How can pharma engage with key decision-makers in new, collaborative NHS care models?

April 10, 2018 |  White Papers and Resources  |

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

Read More

Brought to you by  Wilmington Healthcare 

Managing local population needs is key for the NHS

March 6, 2018 |  White Papers and Resources  |

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma

Read More

Brought to you by  Wilmington Healthcare 

Large-scale NHS commissioning models require new partnership approach from pharma

February 1, 2018 |  White Papers and Resources  |

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working

Read More

Brought to you by  Wilmington Healthcare 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links